Template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract: Impact on patient survival

International Journal of Urology

Volumn 17, Issue 10, 2010, Pages 848-854

  Kondo, Tsunenori ^a   Hashimoto, Yasunobu ^a   Kobayashi, Hirohito ^a   Iizuka, Junpei ^a   Nakazawa, Hayakazu ^b   Ito, Fumio ^b   Tanabe, Kazunari ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

kidney pelvis; lymph node excision; lymphatic metastasis; transitional cell carcinoma; ureteral neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; NEPHROURETERECTOMY; PRIORITY JOURNAL; URINARY TRACT CARCINOMA; UROTHELIAL CARCINOMA OF THE UPPER URINARY TRACT;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; NEPHRECTOMY; PELVIS; SURVIVAL ANALYSIS; URETERAL NEOPLASMS;

EID: 77957268658     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2010.02610.x     Document Type: Article

References (23)

1. Sagalowsky AI, Jarrett TW. Management of urothelial tumors of the renal pelvis and ureter. In : Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds). Campbell-Walsh Urology, 9th edn. Saunders
2. Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H, Tanabe K. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. Urology 2007 69 : 265 9. (Pubitemid 46274933)
3. Kondo T, Nakazawa H, Ito F, Hashimoto Y, Toma H, Tanabe K. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. J. Urol. 2007 178 : 1212 17 discussion 1217. (Pubitemid 47368417)
4. Roscigno M, Cozzarini C, Bertini R et al. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur. Urol. 2008 53 : 794 802.
5. Brausi MA, Gavioli M, De Luca G et al. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. Eur. Urol. 2007 52 : 1414 20. (Pubitemid 47445989)
6. Konety BR, Joslyn SA, O'Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J. Urol. 2003 169 : 946 50.
7. Stein JP, Skinner DG. The role of lymphadenectomy in high-grade invasive bladder cancer. Urol. Clin. North Am. 2005 32 : 187 97.
8. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J. Urol. 2002 167 : 1295 8. (Pubitemid 34132073)
9. Leissner J, Ghoneim MA, Abol-Enein H et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J. Urol. 2004 171 : 139 44. (Pubitemid 37549109)
10. Koppie TM, Vickers AJ, Vora K, Dalbagni G, Bochner BH. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Cancer 2006 107 : 2368 74. (Pubitemid 44748519)
11. Knap MM, Lundbeck F, Overgaard J. The role of pelvic lymph node dissection as a predictive and prognostic factor in bladder cancer. Eur. J. Cancer 2003 39 : 604 13. (Pubitemid 36287372)
12. Roscigno M, Shariat SF, Margulis V et al. The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur. Urol. 2009 56 : 512 18.
13. Lughezzani G, Jeldres C, Isbarn H et al. A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma. Urology 2010 75 : 118 24.
14. Abe T, Shinohara N, Harabayashi T et al. The role of lymph-node dissection in the treatment of upper urinary tract cancer: a multi-institutional study. BJU Int. 2008 102 : 576 80.
15. Sobin LH, Wittekind CH. Renal Plevis and Ureter (ICD-O C65, C66). TNM Classification of Malignant Tumors, 6th edn.
16. Bochner BH, Herr HW, Reuter VE. Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J. Urol. 2001 166 : 2295 6.
17. Stein JP, Cai J, Groshen S, Skinner DG. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J. Urol. 2003 170 : 35 41. (Pubitemid 36734405)
18. Bochner BH, Cho D, Herr HW, Donat M, Kattan MW, Dalbagni G. Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. J. Urol. 2004 172 : 1286 90. (Pubitemid 39249699)
19. Herr H, Lee C, Chang S, Lerner S. Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. J. Urol. 2004 171 : 1823 8 discussion 1827-8. (Pubitemid 38501012)
20. Skinner DG. Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J. Urol. 1982 128 : 34 6.
21. Poulsen AL, Horn T, Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J. Urol. 1998 160 6 Pt 1) 2015 19 discussion 2020.
22. Stein JP. Lymphadenectomy in bladder cancer: how high is "high enough". Urol. Oncol. 2006 24 : 349 55.
23. Dalbagni G. Editorial Comment on: the extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed? Eur. Urol. 2009 56 : 519.